Showing results (91-100 of 482) with videos related to
Sort By:
Pageof 49
Experimental Cell Research|September 3, 2014
Dissecting the role of polarity regulators in cancer through the use of mouse modelsNathan J Gödde, Helen B Pearson, Lorey K Smith, et al.Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|June 5, 2015
Safety of Rural Nursing Home-to-Emergency Department Transfers: Improving Communication and Patient Information Sharing Across SettingsJudith B Tupper, Carolyn E Gray, Karen B Pearson, et al.Elife|February 27, 2019
Somatic mutations in early metazoan genes disrupt regulatory links between unicellular and multicellular genes in cancerAnna S Trigos, Richard B Pearson, Anthony T Papenfuss, et al.The Journal of Biological Chemistry|August 5, 1993
The immunosuppressant rapamycin induces inactivation of p70s6k through dephosphorylation of a novel set of sitesS Ferrari, R B Pearson, M Siegmann, et al.Cancer Management and Research|September 7, 2013
AKT-independent PI3-K signaling in cancer - emerging role for SGK3Maressa A Bruhn, Richard B Pearson, Ross D Hannan, et al.Perceptual and Motor Skills|October 1, 1981
Psychometric properties of two measures of intrinsic motivationA B Silverstein, L B Pearson, B F Dunnick, et al.Biomed Research International|July 28, 2018
Cystathionine β-Synthase in Physiology and CancerHaoran Zhu, Shaun Blake, Keefe T Chan, et al.Growth Factors (Chur, Switzerland)|October 6, 2010
Second AKT: the rise of SGK in cancer signallingMaressa A Bruhn, Richard B Pearson, Ross D Hannan, et al.Peptide Research|May 1, 1991
Myosin light chain kinase autoregulatory pseudosubstrate prototopeR B Pearson, J T Hunt, K I Mitchelhill, et al.Biochimica Et Biophysica Acta|December 3, 2014
The nucleolus as a fundamental regulator of the p53 response and a new target for cancer therapySimone J Woods, Katherine M Hannan, Richard B Pearson, et al.Pageof 49